Nuvectis Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	127	145	110	-	-
Market Cap Growth	-24.66%	31.58%	-	-	-
Enterprise Value	107	122	86	-	-
Last Close Price	8.20	8.34	7.50	-	-
PE Ratio	-	-5.83	-4.97	-	-
PB Ratio	8.99	11.84	7.72	-	-
P/FCF Ratio	-9.38	-9.06	-8.10	-	-
P/OCF Ratio	-9.38	-9.06	-8.10	-	-
EV/EBIT Ratio	-5.70	-5.59	-4.78	-	-
EV/FCF Ratio	-8.15	-7.67	-6.36	-	-
Quick Ratio	3.42	2.74	3.23	2.37	-
Current Ratio	3.46	2.75	3.30	2.41	-
Return on Equity (ROE)	-170.23%	-168.51%	-206.81%	-609.74%	-
Return on Assets (ROA)	-77.22%	-69.14%	-83.30%	-	-
Return on Capital (ROIC)	-105.49%	-103.60%	-122.14%	-171.30%	-
Earnings Yield	-17.75%	-15.40%	-17.38%	-	-
FCF Yield	-12.32%	-11.04%	-12.35%	-	-
Buyback Yield / Dilution	-12.46%	-22.90%	-196.55%	-9.44%	-
Total Shareholder Return	-12.46%	-22.90%	-196.55%	-9.44%	-

Source: S&P Capital IQ. Standard template.